EE02998B1 - Propellendivaba inhalatsiooniseade - Google Patents

Propellendivaba inhalatsiooniseade

Info

Publication number
EE02998B1
EE02998B1 EE9400230A EE9400230A EE02998B1 EE 02998 B1 EE02998 B1 EE 02998B1 EE 9400230 A EE9400230 A EE 9400230A EE 9400230 A EE9400230 A EE 9400230A EE 02998 B1 EE02998 B1 EE 02998B1
Authority
EE
Estonia
Prior art keywords
inhalation device
propellant
dose
dosing
free inhalation
Prior art date
Application number
EE9400230A
Other languages
English (en)
Estonian (et)
Inventor
Rajaram Gupte Arun
Dieter Ruthemann Hans
Kusti Antero Auvinen Raimo
Pekka Juhani Karttunen Kauko
Tapio Vidgren Mika
Kladders Heinrich
Zierenberg Bernd
Original Assignee
Boehringer Ingelheim Kg
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg, Orion Corporation filed Critical Boehringer Ingelheim Kg
Publication of EE02998B1 publication Critical patent/EE02998B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • A61M15/0025Mouthpieces therefor with caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Manipulator (AREA)
  • Nozzles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Steroid Compounds (AREA)
EE9400230A 1990-11-29 1994-11-23 Propellendivaba inhalatsiooniseade EE02998B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909026025A GB9026025D0 (en) 1990-11-29 1990-11-29 Inhalation device

Publications (1)

Publication Number Publication Date
EE02998B1 true EE02998B1 (et) 1997-06-16

Family

ID=10686227

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400230A EE02998B1 (et) 1990-11-29 1994-11-23 Propellendivaba inhalatsiooniseade

Country Status (28)

Country Link
US (1) US5575280A (cs)
EP (1) EP0559663B1 (cs)
JP (1) JP3287844B2 (cs)
KR (1) KR0183376B1 (cs)
CN (1) CN1054546C (cs)
AT (1) ATE109361T1 (cs)
BR (1) BR9107096A (cs)
CA (1) CA2097288C (cs)
CZ (1) CZ281346B6 (cs)
DE (1) DE69103281T2 (cs)
DK (1) DK0559663T3 (cs)
EE (1) EE02998B1 (cs)
ES (1) ES2057921T3 (cs)
FI (1) FI105892B (cs)
GB (1) GB9026025D0 (cs)
HK (1) HK1000204A1 (cs)
HU (1) HU212398B (cs)
IE (1) IE73254B1 (cs)
IL (1) IL100038A (cs)
LT (1) LT3123B (cs)
LV (1) LV10397B (cs)
NO (1) NO305466B1 (cs)
NZ (1) NZ240573A (cs)
PL (1) PL167216B1 (cs)
RU (1) RU2097069C1 (cs)
SK (1) SK278780B6 (cs)
WO (1) WO1992009322A1 (cs)
ZA (1) ZA919388B (cs)

Families Citing this family (176)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016759A1 (en) * 1991-03-05 1994-08-04 Miris Medical Corporation An automatic aerosol medication delivery system and methods
US6029661A (en) * 1991-08-26 2000-02-29 3M Innovative Properties Company Powder dispenser
GB9203761D0 (en) * 1992-02-21 1992-04-08 Innovata Biomed Ltd Inhaler
IL106930A0 (en) * 1992-09-08 1993-12-28 Norton Healthcare Ltd Medicament dispensing device
DE4239402A1 (de) * 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US7448375B2 (en) 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6098620A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Device for aerosolizing narcotics
US6024090A (en) 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5558085A (en) * 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5672581A (en) * 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5934272A (en) * 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5709202A (en) * 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
DE4340768A1 (de) * 1993-11-30 1995-06-01 Bayer Ag Vorrichtung zum Inhalieren
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
FI942196L (fi) * 1994-05-11 1995-11-12 Orion Yhtymae Oy Jauheinhalaattori
FI95441C (fi) * 1994-05-31 1996-02-12 Leiras Oy Inhalointilaitteen lääkeainekammio
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
DE19518810A1 (de) * 1995-05-26 1996-11-28 Bayer Ag Nasal-Applikator
CZ294700B6 (cs) * 1995-06-21 2005-02-16 Sofotec Gmbh & Co. Kg Pouzdro na farmaceutický prášek pro práškové inhalátory
SE504458C2 (sv) * 1995-06-21 1997-02-17 Lars Gunnar Nilsson Inhalator för elektrisk dosering av substanser
FI102875B1 (fi) * 1995-11-10 1999-03-15 Orion Yhtymae Oy Jauheinhalaattori
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
SE9700938D0 (sv) * 1997-03-14 1997-03-14 Astra Ab Powder inhaler II and a method of construction thereof
US6182712B1 (en) 1997-07-21 2001-02-06 Inhale Therapeutic Systems Power filling apparatus and methods for their use
DE19825434C2 (de) * 1998-01-30 2002-03-28 Ig Spruehtechnik Gmbh Inhalationsgerät für pulverförmige Medikamente
SK285463B6 (sk) 1998-01-30 2007-02-01 Mibe Gmbh Arzneimittel Inhalačné zariadenie na práškové formy
GB9827200D0 (en) * 1998-12-11 1999-02-03 Glaxo Group Ltd Dry powder inhaler
US6223744B1 (en) 1999-03-16 2001-05-01 Multi-Vet Ltd. Wearable aerosol delivery apparatus
FI108518B (fi) * 1999-04-23 2002-02-15 Orion Yhtymae Oyj Jauheinhalaattori yhdistelmälääkkeelle
FI107126B (fi) * 1999-04-23 2001-06-15 Orion Yhtymae Oyj Jauheinhalaattori yhdistelmälääkkeelle
MXPA01012533A (es) * 1999-06-05 2003-10-14 Innovata Biomed Ltd Sistema de suministro.
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
GB9928265D0 (en) * 1999-12-01 2000-01-26 Innovata Biomed Ltd Inhaler
US6926003B2 (en) 1999-12-07 2005-08-09 Orion Corporation Multidose powder inhaler
US7304750B2 (en) * 1999-12-17 2007-12-04 Nektar Therapeutics Systems and methods for non-destructive mass sensing
WO2001078817A1 (en) * 2000-02-25 2001-10-25 Dura Pharmaceuticals, Inc. Dosing system for a dry powder inhaler
WO2001064182A2 (en) 2000-02-28 2001-09-07 Vectura Limited Improvements in or relating to the delivery of oral drugs
FI20000810A0 (fi) * 2000-04-06 2000-04-06 Orion Yhtymae Oyj Jauheinhalaattori
GB2364649A (en) * 2000-05-17 2002-02-06 Orion Corp Inhaler with Dose Counter
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
WO2002034318A2 (en) * 2000-10-20 2002-05-02 Glaxo Group Limited Inhaler
FI20002363A0 (fi) 2000-10-27 2000-10-27 Orion Yhtymae Oyj Jauheinhalaattori
FI20010538A0 (fi) * 2001-03-16 2001-03-16 Orion Corp Jauheinhalaattori
GB0107106D0 (en) * 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
FI20011317A0 (fi) * 2001-06-20 2001-06-20 Orion Corp Jauheinhalaattori
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
GB2384198B (en) * 2002-01-18 2005-03-02 Profile Drug Delivery Ltd Nebulizer metering
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
JP2005527508A (ja) 2002-03-07 2005-09-15 ヴェクトゥラ リミテッド 経口デリバリー用急速溶融多粒子製剤
US7185651B2 (en) 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
PT1515890E (pt) * 2002-06-27 2012-10-18 Novartis Ag Dispositivo e método para controlar o escoamento de um pó
ES2262730T3 (es) 2002-07-31 2006-12-01 Chiesi Farmaceutici S.P.A. Inhalador de polvo.
AU2003272935C1 (en) * 2002-10-11 2009-06-25 Otsuka Pharmaceutical Co., Ltd. Powder inhalation device
RU2245169C1 (ru) * 2003-07-22 2005-01-27 Варламов Сергей Евгеньевич Устройство дозирования лекарственных средств
US20050026948A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE202004007115U1 (de) * 2004-05-03 2004-07-08 Altana Pharma Ag Blindungsvorrichtung
EP1765405A1 (en) 2004-05-31 2007-03-28 Laboratorios Almirall, S.A. Combinations comprising antimuscarinic agents and corticosteroids
ES2257152B1 (es) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
US7187595B2 (en) * 2004-06-08 2007-03-06 Saifun Semiconductors Ltd. Replenishment for internal voltage
EP1616592B9 (en) 2004-07-16 2011-02-02 Almirall, S.A. Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge for use with this inhaler
RU2281124C1 (ru) * 2004-12-16 2006-08-10 Сергей Евгеньевич Варламов Устройство дозирования лекарственных средств
GB0427856D0 (en) 2004-12-20 2005-01-19 Glaxo Group Ltd Maniflod for use in medicament dispenser
GB0427858D0 (en) 2004-12-20 2005-01-19 Glaxo Group Ltd Manifold for use in medicament dispenser
RU2282569C1 (ru) * 2005-02-24 2006-08-27 Сергей Евгеньевич Варламов Устройство дозирования сыпучих пищевых продуктов
US7694676B2 (en) * 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
WO2006119766A1 (en) * 2005-05-10 2006-11-16 Bang & Olufsen Medicom A/S Forward metering valve
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
AU2006247053B2 (en) 2005-05-18 2013-05-23 Horizon Therapeutics U.S. Holding Llc Aerosolized fluoroquinolones and uses thereof
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
US8235044B2 (en) * 2005-08-01 2012-08-07 Astrazeneca Ab Inhaler valve
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
PT103481B (pt) * 2006-05-16 2008-08-01 Hovione Farmaciencia S A Inalador de uso simples e método de inalação
MY147787A (en) * 2006-06-27 2013-01-31 Otsuka Pharma Co Ltd Powder inhaler
DE102006032293A1 (de) * 2006-07-11 2008-01-24 Friedrich Sanner Gmbh & Co. Kg Vorrichtung zur dosierten Abgabe von versprühbaren Stoffen
ES2378786T3 (es) 2006-12-22 2012-04-17 Almirall, S.A. Dispositivo de inhalación para fármacos en forma de polvo
ES2306595B1 (es) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
US8496002B2 (en) * 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
US20090211576A1 (en) * 2007-10-02 2009-08-27 Timo Lehtonen Safety and abuse deterrent improved device
ES2320961B1 (es) 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
EP2096105A1 (en) 2008-02-28 2009-09-02 Laboratorios Almirall, S.A. Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
MX345158B (es) 2008-10-07 2017-01-18 Raptor Pharmaceuticals Inc Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
WO2010077278A1 (en) * 2008-12-09 2010-07-08 Becton, Dickinson And Company Dual-chambered drug delivery device for high pressure injections
PL2373373T3 (pl) 2008-12-15 2014-05-30 Profibrix Bv Dozownik proszku
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
UY32297A (es) 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
EP2221055A1 (en) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
EP2221297A1 (en) 2009-02-18 2010-08-25 Almirall, S.A. 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2228368A1 (en) 2009-03-12 2010-09-15 Almirall, S.A. Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
GB0910537D0 (en) 2009-06-18 2009-07-29 Ivax Pharmaceuticals Ireland Inhaler
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
EP2322176A1 (en) 2009-11-11 2011-05-18 Almirall, S.A. New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
EP2498848A2 (en) 2009-11-12 2012-09-19 Stc.Unm Dry powder inhaler with flutter dispersion member
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2463289A1 (en) 2010-11-26 2012-06-13 Almirall, S.A. Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
CN102553038B (zh) * 2010-12-17 2014-07-02 陈庆堂 药粉吸嘴放置盒
GB201021881D0 (en) 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2518071A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridine derivatives as PI3K inhibitors
EP2518070A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors
EP2527344A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
EP2526945A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. New CRTH2 Antagonists
EP2548876A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists
EP2548863A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists.
EP2554544A1 (en) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
GB201118842D0 (en) 2011-11-01 2011-12-14 Euro Celtique Sa Dispenser cap arrangement
EP2592077A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
GB2499597A (en) * 2012-02-21 2013-08-28 Innovata Biomed Ltd Dry powder inhaler with stepped rotation of metering member
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP2647627A1 (en) 2012-04-02 2013-10-09 Almirall, S.A. Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
EP2666465A1 (en) 2012-05-25 2013-11-27 Almirall, S.A. Novel dosage and formulation
EP2668941A1 (en) 2012-05-31 2013-12-04 Almirall, S.A. Novel dosage form and formulation of abediterol
WO2014060431A1 (en) 2012-10-16 2014-04-24 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
KR20150096732A (ko) 2012-12-18 2015-08-25 알미랄, 에스.에이. 베타2 아드레날린 아고니스트 및 m3 무스카린 안타고니스트 활성을 갖는 새로운 시클로헥실 및 퀴누클리디닐 카르바메이트 유도체
TW201446767A (zh) 2013-02-15 2014-12-16 Almirall Sa 作為磷脂肌醇3-激酶抑製劑之吡咯並三嗪衍生物
EP2848615A1 (en) 2013-07-03 2015-03-18 Almirall, S.A. New pyrazole derivatives as CRAC channel modulators
CA2919498C (en) 2013-07-31 2023-07-25 Windward Pharma, Inc. Aerosol nintedanib compounds and uses thereof
TWI577398B (zh) * 2013-11-01 2017-04-11 卡貝歐洲有限公司 咬嘴和吸氣器
WO2015091287A1 (en) 2013-12-19 2015-06-25 Almirall S.A. Dosage formulation comprising salmeterol and fluticasone propionate
US9770443B2 (en) 2014-01-10 2017-09-26 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10561806B2 (en) * 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
DE102014017409B4 (de) * 2014-11-26 2016-06-09 Klaus Dieter Beller Einzeldosis-Pulverinhalator und Verfahren zu dessen Herstellung
EP3244952A4 (en) 2015-01-14 2018-11-14 Respira Therapeutics, Inc. Powder dispersion methods and devices
WO2016170009A1 (en) 2015-04-21 2016-10-27 Almirall, S.A. Amino-substituted heterocyclic derivatives as sodium channel inhibitors
CN106275880A (zh) * 2015-06-07 2017-01-04 王龙 一种粉料定量供给装置
WO2016202800A1 (en) 2015-06-16 2016-12-22 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
CN105169536A (zh) * 2015-07-17 2015-12-23 山东京卫制药有限公司 干粉吸入装置
WO2017076990A1 (en) 2015-11-05 2017-05-11 Almirall, S.A. Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
US10716904B2 (en) * 2016-07-21 2020-07-21 Philip Morris Products S.A. Dry powder inhaler
JP2018184259A (ja) * 2017-04-26 2018-11-22 川崎重工業株式会社 粉粒体供給装置
TW201919682A (zh) 2017-08-08 2019-06-01 西班牙商阿爾米雷爾有限公司 活化Nrf2路徑的新穎化合物
CA3094244A1 (en) * 2018-03-30 2019-10-03 Nick MARIANI Inhaler and method
US12036358B2 (en) 2018-09-10 2024-07-16 Cipla Limited Single blister-strip based dispenser
CN110064110A (zh) * 2019-05-29 2019-07-30 上海理工大学 一种容积旋钮式干粉储存吸入装置
KR102021096B1 (ko) * 2019-07-30 2019-09-11 (주)지에이치이노텍 호흡 재활 장치
CN110817062A (zh) * 2019-12-03 2020-02-21 平湖市聚顶包装有限公司 一种可存放两种茶叶的密封保存盒
CN111617374B (zh) * 2020-07-01 2021-02-26 刘平平 一种口腔溃疡用药粉辅助喷涂装置
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof
EP4452372A1 (en) 2021-12-21 2024-10-30 Chiesi Farmaceutici S.p.A. Powder inhaler

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE179227C (cs)
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
US3973566A (en) * 1975-01-13 1976-08-10 Syntex Puerto Rico Inc. Inhalation device
US4274403A (en) * 1979-08-29 1981-06-23 Struve Roger L Inhaler
US4307734A (en) * 1980-06-23 1981-12-29 B & B Inventors & Marketers, Inc. Snuff dispenser
ES8206980A1 (es) * 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
EP0079478A1 (en) * 1981-11-03 1983-05-25 Miles Laboratories, Inc. Medicament inhalation device
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
US4709837A (en) * 1984-05-01 1987-12-01 Merck & Co., Inc. Filter assembly for dry powder filling machine
FI69963C (fi) 1984-10-04 1986-09-12 Orion Yhtymae Oy Doseringsanordning
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel

Also Published As

Publication number Publication date
DK0559663T3 (da) 1994-09-26
AU8844391A (en) 1992-06-25
CA2097288C (en) 1996-12-31
CZ281346B6 (cs) 1996-08-14
CN1054546C (zh) 2000-07-19
IE73254B1 (en) 1997-05-21
DE69103281D1 (de) 1994-09-08
FI932421A7 (fi) 1993-05-27
LTIP340A (lt) 1994-08-25
NZ240573A (en) 1995-05-26
PL167216B1 (en) 1995-08-31
EP0559663A1 (en) 1993-09-15
ES2057921T3 (es) 1994-10-16
EP0559663B1 (en) 1994-08-03
GB9026025D0 (en) 1991-01-16
DE69103281T2 (de) 1994-11-24
RU2097069C1 (ru) 1997-11-27
ZA919388B (en) 1993-05-28
HUT65186A (en) 1994-05-02
BR9107096A (pt) 1993-10-13
HU212398B (en) 1996-06-28
KR930702040A (ko) 1993-09-08
NO931969L (no) 1993-05-28
US5575280A (en) 1996-11-19
ATE109361T1 (de) 1994-08-15
IL100038A (en) 1996-01-19
SK54693A3 (en) 1993-09-09
NO931969D0 (no) 1993-05-28
FI105892B (fi) 2000-10-31
CA2097288A1 (en) 1992-05-30
CN1062847A (zh) 1992-07-22
CZ102093A3 (en) 1993-11-17
WO1992009322A1 (en) 1992-06-11
KR0183376B1 (ko) 1999-04-01
NO305466B1 (no) 1999-06-07
LV10397B (en) 1995-04-20
LV10397A (lv) 1995-02-20
IE914145A1 (en) 1992-06-03
SK278780B6 (sk) 1998-02-04
IL100038A0 (en) 1992-08-18
HK1000204A1 (en) 1998-02-06
LT3123B (en) 1994-12-27
FI932421A0 (fi) 1993-05-27
JPH06502784A (ja) 1994-03-31
HU9301590D0 (en) 1993-11-29
JP3287844B2 (ja) 2002-06-04
AU659110B2 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
DK0559663T3 (da) Inhalationsindretning
YU68594A (sh) Naprava za inhaliranje
RU93032035A (ru) Устройство для ингаляции
SE9700937D0 (sv) Powder inhaler I
SE9700423D0 (sv) Disposable inhaler
DE69121724D1 (de) Pulverinhalator
RU93043618A (ru) Ингалятор без нагнетательного газа
ATE116558T1 (de) Treibgasfreies inhalationsgerät mit fremdluftstrom.
ATE305321T1 (de) Inhalator
SE9700940D0 (sv) Powder inhaler IV
EE04803B1 (et) Mitmedoosiline inhalatsiooniaparaat pulbrilisel kujul ravimi manustamiseks
DE60020597D1 (de) Mehrfachpulverinhalator
MX9704489A (es) Dispositivo de inhalacion, metodo para dispersar una sustancia farmaceuticamente activa y metodo para administrar una dosis de una sustancia farmaceuticamente activa.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231